Peptide-Poly(L-lysine citramide) conjugates and their in vitro anti-HIV behavior

Biomacromolecules

Volumn 10, Issue 4, 2009, Pages 865-876

  Couffin Hoarau, Anne Claude ^a   Aubertin, Anne Marie ^a   Boustta, Mahfoud ^a   Schmidt, Sylvie ^a   Fehrentz, Jean Alain ^b   Martinez, Jean ^b   Vert, Michel ^a  

^a UNIVERSITÉ DE MONTPELLIER   (France)

^b UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE TOXICITIES; AMINO-ACID; ANTI-HIV; ANTI-HIV ACTIVITIES; ANTIVIRAL ACTIVITIES; BIORESORBABLE; BUILDING BLOCKS; CAPILLARY ZONE ELECTROPHORESIS; CELL LINES; CELL PENETRATIONS; CELLULAR FLUIDS; FTIR; HIV PROTEASE; IN-VITRO; L LYSINES; METHYL ESTERS; NEGATIVE CONTROLS; PEPTIDE MOIETIES; PEPTIDE RELEASE; PH VALUES; PHYSICO-CHEMICAL PROPERTIES; POLYANION; POLYMER CHAINS; POLYMERIC DRUG CARRIERS; PSEUDO PEPTIDES;

ACIDS; AMINATION; AMINO ACIDS; CAPILLARY ELECTROPHORESIS; CELL CULTURE; ESTERIFICATION; ESTERS; FOURIER TRANSFORM INFRARED SPECTROSCOPY; POLYMERS; TOXICITY; VIRUSES;

AMINES;

AMINO 3 HYDROXY 5 PHENYLPENTANOYL ISOLEUCYL PHENYLALANINE METHYL ESTER; FLUORESCENT DYE; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; LYSINE DERIVATIVE; PEPTIDE; PHENYLALANYL ISOLEUCYL PHENYLALALINE METHYL ESTER PEPTIDE; POLY(LYSINE CITRAMIDE); POLYMER; PROTEINASE; PSEUDOPEPTIDE; UNCLASSIFIED DRUG; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; HUMAN IMMUNODEFICIENCY VIRUS PROTEINASE INHIBITOR; LYSINE; PEPTIDE FRAGMENT; POLYLYSINE;

AMINO ACID ANALYSIS; ANIMAL EXPERIMENT; ANTIVIRAL ACTIVITY; CAPILLARY ZONE ELECTROPHORESIS; CELL LINE; CONFERENCE PAPER; CONJUGATE; CONTROLLED STUDY; DEGRADATION; DRUG ACTIVITY; DRUG DELIVERY SYSTEM; DRUG STRUCTURE; DRUG SYNTHESIS; EXTRACELLULAR FLUID; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; IN VITRO STUDY; LIGHT SCATTERING; LYMPHATIC LEUKEMIA; LYMPHOID CELL; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PH; POLYMERIZATION; PRIORITY JOURNAL; SOLUBILITY; TOXICITY; ANALOGS AND DERIVATIVES; ANIMAL; BODY WEIGHT; CHEMISTRY; CYTOLOGY; DRUG EFFECTS; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HIV INFECTIONS; HUMAN IMMUNODEFICIENCY VIRUS 1; IC50; INFRARED SPECTROSCOPY; LYMPHOCYTE; METABOLISM; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; THIN LAYER CHROMATOGRAPHY;

ANIMALS; ANTI-HIV AGENTS; BODY WEIGHT; CELL LINE; CHROMATOGRAPHY, THIN LAYER; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HIV-1; HUMANS; INHIBITORY CONCENTRATION 50; LYMPHOCYTES; LYSINE; MAGNETIC RESONANCE SPECTROSCOPY; MICE; PEPTIDE FRAGMENTS; POLYLYSINE; POLYMERS; SPECTROSCOPY, FOURIER TRANSFORM INFRARED;

HUMAN IMMUNODEFICIENCY VIRUS 1; MUS;

EID: 65249174487     PISSN: 15257797     EISSN: None     Source Type: Journal    
DOI: 10.1021/bm801376v     Document Type: Conference Paper

References (34)

1. Pearl, L. H.; Taylor, W. R. Nature 1987, 329, 351-354.
2. Wlodawer, A.; Miller, M.; Jaskolsky, M.; Sathyanarayana, B. K.; Baldwin, E.; Weber, I. T.; Selk, L. M.; Clawson, L.; Schneider, J.; Kent, S. B. H. Science 1989, 245, 616-621.
3. Barry, M.; Gibbons, S.; Back, D.; Mulcahy, F. Clin. pharmacokinet. 1997, 32, 194-209.
4. Reedijk, M.; Boucher, C. A.; van Bommel, T. Antimicrob. Agents Chemother. 1995, 39, 1559-1564.
5. Ringsdorf, H. J. Pohm. Sci., Pohm. Symp. 1975, 51, 135-153.
6. Vicent, M. J.; Duncan, R. Trends Biotechnol. 2006, 24, 39-19.
7. Kopecek, J.; Cifkova, I.; Rejmanova, P.; Strohalm, J.; Obereigner, B.; Ulbrich, K. Makromol. Chem. 1981, 182, 2941-2949.
8. Abdellaoui, K.; Boustta, M.; Vert, M.; Morjani, H.; Manfait, M. Eur. J. Pharm. Sci. 1998, 6, 61-73.
9. Mrkvan, T.; Sirova, M.; Etrych, T.; Chytil, P.; Strohalm, J.; Plocova, D.; Ulbrich, K.; Rihova, B. J. Controlled Release 2005, 110, 119-129.
10. Hoste, K.; De Winne, K.; Schacht, E. Int. J. Pharm. 2004, 277, 119-131.
11. Chung, I.; Lee, C. K.; Ha, C. S.; Cho, W. J. J. Polym. Sci., Part A: Polym. Chem. 2006, 44, 295-303.
12. Gao, Y.; Katsuraya, K.; Kaneko, Y.; Mimura, Y.; Nakashima, H.; Uryu, T. Macromolecules 1999, 32, 8319-8324.
13. Vlieghe, P.; Clerc, T.; Pannecouque, C.; Witvrouw, M.; De Clercq, E.; Salle, J. P.; Kraus, J. L. J. Med. Chem. 2002, 45, 1275-1283.
14. Garrouste, P.; Pawlowski, M.; Tonnaire, T.; Sicsic, S.; Durny, P.; de Rosny, E.; Reboud-Ravaux, M.; Fulcrand, P.; Martinez, J. Eur .J. Med. Chem. 1998, 33, 423-436.
15. Raju, B.; Deshpande, M. S. Biochem. Biophys. Res. Commun. 1991, 180, 187-190.
16. Vert, M. Crit. Rev. Ther. Drue Carrier Syst. 1986, 2, 291-327.
17. Boustta, M.; Huguet, J.; Vert, M. Makromol. Chem., Macromol. Symp. 1991, 47, 345-355.
18. Couffin-Hoarau, A. C.; Boustta, M.; Vert, M. J. Polym. Sci., Part A: Polym. Chem. 2001, 39, 3475-3484.
19. Gautier, S.; Boustta, M.; Vert, M. J. Controlled Release 1999, 60, 235-247.
20. Gac, S.; Coudane, J.; Boustta, M.; Domurado, M.; Vert, M. J. Drug Targeting 2000, 7, 393-406.
21. Gac-Breton, S.; Coudane, J.; Boustta, M.; Vert, M. J. Drug Targeting 2004, 12, 297-307.
22. Abdellaoui, K.; Boustta, M.; Morjani, H.; Manfait, M.; Vert, M. J. Drug Targeting 1997, 5, 193-206.
23. Henin, O.; Boustta, M.; Domurado, M.; Coudane, J.; Domurado, D.; Vert, M. J. Bioact. Compat. Polym. 1998, 13, 19-32.
24. Pauwels, R.; Andries, K.; Desmyter, J.; Schols, D.; Kuhla, M. J.; Breslin, H. J.; Rayemaeckers, A.; Van Gelder, J.; Woestenborghs, R.; Heykants, J.; Schellenkens, K.; Janssen, M. A. C.; De Clercq, E.; Janssen, P. A. J. Nature 1990, 343, 470-474.
25. Chou, J.; Chou, T.-C. In Computer software for Apple II and IBM- PC and instruction manual; Biosoft, E., Ed.; Elsevier Science Publishers: Cambridge, U.K., 1985, pp 19-25.
26. Moog, C.; Wick, A. P. L. B.; Kirn, A.; Aubertin, A. M. Antiviral Res. 1994, 24, 275-288.
27. Mosmann, T. J. Immunol. Methods 1983, 65, 55-63.
28. Gautier, S.; Boustta, M.; Vert, M. J. Bioact. Compat. Polym. 1997, 12, 77-98.
29. Domurado, D.; Vert, M. J. Biomater. Sci., Polym. Ed. 2007, 18, 287-301.
30. Witvrouw, M.; Desmyter, J. E. D. C. Antiviral Chem. Chemother. 1994, 5, 345-359.
31. Chang, T. L.; Telesshova, N.; Rapista, A.; Paluch, M.; Anderson, R. A.; Waller, D. P.; Zaneveld, L. J. D.; Granelli-Piperno, A.; Klotman, M. E. FEBS Lett. 2007, 581, 4596-4602.
32. Neyts, J.; Reymen, D.; Letourneur, D.; Jozefonvicz, J.; Schols, D.; Este, J.; Andrei, G.; McKenna, P.; Witvrouw, M.; Ikeda, S. Biochem. Pharmacol. 1995, 50, 743-751.
33. Herold, B. C.; Scordi-Bello, J.; Cheshenko, N.; Marcellino, D.; Dzuzelewski, M.; Francois, F.; Morin, R.; Mas Casullo, V.; Anderson, R. A.; Chany, C., II.; Waller, D. P.; Zaneveld, L. J. D.; Klotman, M. E. J. Virol. 2002, 76, 11236-11244.
34. Moulard, M.; Lortat-Jacob, H.; Modor, I.; Roca, G.; Wyatt, R.; Sodroski, J.; Zhao, L.; Olson, W.; Kwong, P. D.; Sattentau, Q. J. J. Virol. 2000, 74, 1948-1960.